{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:13:38Z","timestamp":1794345218028,"version":"4.9.0"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Smoldering inflammation and neurodegeneration, primarily driven by intraparenchymal immune cell activation and glial dysfunction, remains a major therapeutic challenge in Multiple Sclerosis (MS) and contributes largely to disability progression. Current disease-modifying therapies effectively decrease relapse rate and, to a lesser extent, disease progression by targeting peripheral immune cells. However, they largely fail to address Central-Nervous-System-(CNS)-intrinsic pathological processes \u2013 especially glial dysfunction \u2013 thus leaving a critical gap relevant to disease progression and therapeutic intervention. In this context, neurotrophic factors (NTF) are secreted proteins central for development and maintenance of the CNS. They promote anti-inflammatory, protective phenotypes in astrocytes and microglia, support remyelination by enhancing oligodendrocyte precursor recruitment, maturation and survival, and exert direct neuroprotective effects. Exploring their role in MS offers a novel perspective on neuroimmune crosstalk and prevention of progressive neurodegeneration. In this article, we summarize relevant findings on NTFs in MS, and give an outlook on opportunities and challenges of using these mediators as next-generation disease-modifying therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1654603","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T04:13:50Z","timestamp":1756268030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Neurotrophic factors in multiple sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Fabian","family":"G\u00fcner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Rothhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s42451-021-00334-6","article-title":"S2k-Leitlinie: Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen","volume":"4","author":"Berthele","year":"2021","journal-title":"DGNeurologie"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.4655","article-title":"Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis","volume":"80","author":"Tur","year":"2023","journal-title":"JAMA Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011788","article-title":"Association of spectral-domain OCT with long-term disability worsening in multiple sclerosis","volume":"96","author":"Lambe","year":"2021","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.1025","article-title":"Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis","volume":"79","author":"Cagol","year":"2022","journal-title":"JAMA Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.573256","article-title":"Protective functions of reactive astrocytes following central nervous system insult","volume":"11","author":"Linnerbauer","year":"2020","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00421-4","article-title":"Towards treating progressive multiple sclerosis","volume":"16","author":"Thompson","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00624-x","article-title":"The role of glial cells in multiple sclerosis disease progression","volume":"18","author":"Healy","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179588","article-title":"Glial cells as key regulators in neuroinflammatory mechanisms associated with multiple sclerosis","volume":"25","author":"Theophanous","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115904","article-title":"Astrocytes in multiple sclerosis-essential constituents with diverse multifaceted functions","volume":"22","author":"Aharoni","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031861","article-title":"Role of microglial cells in the pathophysiology of MS: synergistic or antagonistic","volume":"24","author":"Mado","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7571-6_1","article-title":"Neurotrophic factors: an overview","volume-title":"Neurotrophic Factors: Methods and Protocols","author":"Skaper","year":"2018"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.3390\/ijms24076321","article-title":"Glia-neurotrophic factor relationships: possible role in pathobiology of neuroinflammation-related brain disorders","volume":"24","author":"Palasz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-1997-6_55","article-title":"Trophic factors: neurotrophic factors","volume-title":"Neuroscience in the 21st Century: From Basic to Clinical","author":"Castr\u00e9n","year":"2013"},{"key":"B17","doi-asserted-by":"publisher","first-page":"20240730","DOI":"10.3390\/ijms25158312","article-title":"Neurotrophins and their receptors: BDNF\u2019s role in GABAergic neurodevelopment and disease","volume":"25","author":"Hern\u00e1ndez-del Ca\u00f1o","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"viii5","DOI":"10.1093\/annonc\/mdz383","article-title":"Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer","volume":"30","author":"Amatu","year":"2019","journal-title":"Ann Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903560306","article-title":"Expression of trk receptors in the developing and adult human central and peripheral nervous system","volume":"356","author":"Muragaki","year":"1995","journal-title":"J Comp Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110698","article-title":"Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration","volume":"209","author":"Colombo","year":"2012","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3990-12.2013","article-title":"Oligodendroglial expression of trkB independently regulates myelination and progenitor cell proliferation","volume":"33","author":"Wong","year":"2013","journal-title":"J Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050906","article-title":"Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma","volume":"96","author":"Wang","year":"1998","journal-title":"Acta Neuropathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00486","article-title":"Effects of neurotrophic factors in glial cells in the central nervous system: expression and properties in neurodegeneration and injury","volume":"10","author":"P\u00f6yh\u00f6nen","year":"2019","journal-title":"Front Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5236.593","article-title":"Neurotrophins and neuronal plasticity","volume":"270","author":"Thoenen","year":"1995","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch Med Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2643-y","article-title":"Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia","volume":"222","author":"Zhang","year":"2012","journal-title":"Psychopharmacol (Berl)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"113162","DOI":"10.1016\/j.bbr.2021.113162","article-title":"The role of pro- and mature neurotrophins in the depression","volume":"404","author":"Xue","year":"2021","journal-title":"Behav Brain Res"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.55782\/ane-2021-028","article-title":"Neurotrophic factors in Alzheimer\u2019s disease: pathogenesis and therapy","volume":"81","author":"L\u00fcbke","year":"2021","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.07.016","article-title":"Heparin-binding epidermal growth factor-like growth factor as a critical mediator of tissue repair and regeneration","volume":"188","author":"Dao","year":"2018","journal-title":"Am J Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01756-6","article-title":"The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology","volume":"25","author":"Linnerbauer","year":"2024","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207777","article-title":"Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer","volume":"21","author":"Colucci-D\u2019Amato","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)90151-1","article-title":"Neurotrophic factor gene expression in astrocytes during development and following injury","volume":"35","author":"Schwartz","year":"1994","journal-title":"Brain Res Bull"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.11.030","article-title":"Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor","volume":"155","author":"Parkhurst","year":"2013","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00107","article-title":"High abundance of BDNF within glutamatergic presynapses of cultured hippocampal neurons","volume":"8","author":"Andreska","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00408","article-title":"Inhibition of inwardly rectifying potassium (Kir) 4.1 channels facilitates brain-derived neurotrophic factor (BDNF) expression in astrocytes","volume":"10","author":"Kinboshi","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biom14010091","article-title":"Genetic dissection of BDNF and trkB expression in glial cells","volume":"14","author":"Niu","year":"2024","journal-title":"Biomolecules"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4267-13.2014","article-title":"Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination","volume":"34","author":"Fulmer","year":"2014","journal-title":"J Neurosci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/biom13050789","article-title":"Mechanisms controlling the expression and secretion of BDNF","volume":"13","author":"Ar\u00e9valo","year":"2023","journal-title":"Biomolecules"},{"key":"B39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neures.2023.02.001","article-title":"Astrocytes and brain-derived neurotrophic factor (BDNF)","volume":"197","author":"Albini","year":"2023","journal-title":"Neurosci Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1463437","article-title":"Neuron and astrocyte specific 5mC and 5hmC signatures of BDNF\u2019s receptor, TrkB","volume":"17","author":"Wei","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-0933-z","article-title":"Regulatory effects of neuroinflammatory responses through brain-derived neurotrophic factor signaling in microglial cells","volume":"55","author":"Lai","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098447","article-title":"The role of BDNF in multiple sclerosis neuroinflammation","volume":"24","author":"Nociti","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1385042","article-title":"The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis","volume":"15","author":"Maiworm","year":"2024","journal-title":"Front Neurol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020332","article-title":"The BDNF val66Met polymorphism (rs6265) modulates inflammation and neurodegeneration in the early phases of multiple sclerosis","volume":"13","author":"Dolcetti","year":"2022","journal-title":"Genes (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm189","article-title":"Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor","volume":"16","author":"Zivadinov","year":"2007","journal-title":"Hum Mol Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pathophys.2010.04.006","article-title":"Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study","volume":"18","author":"Ramasamy","year":"2011","journal-title":"Pathophysiology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-010-0433-z","article-title":"BDNF Val66Met polymorphism and brain volumes in multiple sclerosis","volume":"32","author":"Dinacci","year":"2011","journal-title":"Neurol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206140","article-title":"BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression","volume":"13","author":"Nociti","year":"2018","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01260.x","article-title":"Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients","volume":"57","author":"Gielen","year":"2003","journal-title":"Scand J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.07.001","article-title":"Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate","volume":"167","author":"Azoulay","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070146","article-title":"Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins","volume":"13","author":"Sarchielli","year":"2007","journal-title":"Mult Scler"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.05.057","article-title":"Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse","volume":"460","author":"Frota","year":"2009","journal-title":"Neurosci Lett"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.11.047","article-title":"A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis","volume":"1256","author":"Liguori","year":"2009","journal-title":"Brain Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2014.11.003","article-title":"Serum BDNF levels are not reliable correlates of neurodegeneration in MS patients","volume":"4","author":"Damasceno","year":"2015","journal-title":"Multiple Sclerosis Related Disord"},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/NRL.0000000000000053","article-title":"Increased serum brain-derived neurotrophic factor in multiple sclerosis patients on interferon-\u03b2 and its impact on functional abilities","volume":"20","author":"Mehrpour","year":"2015","journal-title":"Neurologist"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2017-0374","article-title":"BDNF and Tau as biomarkers of severity in multiple sclerosis","volume":"12","author":"Islas-Hernandez","year":"2018","journal-title":"biomark Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51215","article-title":"Levels of brain-derived neurotrophic factor in patients with multiple sclerosis","volume":"7","author":"Naegelin","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"103984","DOI":"10.1016\/j.msard.2022.103984","article-title":"Blood levels of brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis (MS): A systematic review and meta-analysis","volume":"65","author":"Karimi","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00319-3","article-title":"Brain-derived neurotrophic factor in patients with multiple sclerosis","volume":"132","author":"Sarchielli","year":"2002","journal-title":"J Neuroimmunology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41598-021-83000-x","article-title":"Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington\u2019s disease","volume":"11","author":"Ou","year":"2021","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"104567","DOI":"10.1016\/j.msard.2023.104567","article-title":"Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study","volume":"71","author":"Yalachkov","year":"2023","journal-title":"Multiple Sclerosis Related Disord"},{"key":"B62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1590\/S0100-879X2011007500165","article-title":"Serum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis","volume":"45","author":"Comini-Frota","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/brain\/awf015","article-title":"BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells","volume":"125","author":"Stadelmann","year":"2002","journal-title":"Brain"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq179","article-title":"Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis","volume":"133","author":"Linker","year":"2010","journal-title":"Brain"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0890-3","article-title":"Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination","volume":"123","author":"Lee","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1592-15.2015","article-title":"Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor","volume":"35","author":"Miyamoto","year":"2015","journal-title":"J Neurosci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0487-18.2018","article-title":"Targeting trkB with a brain-derived neurotrophic factor mimetic promotes myelin repair in the brain","volume":"38","author":"Fletcher","year":"2018","journal-title":"J Neurosci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24003","article-title":"CHPG enhances BDNF and myelination in cuprizone-treated mice through astrocytic metabotropic glutamate receptor 5","volume":"69","author":"Saitta","year":"2021","journal-title":"Glia"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b00644","article-title":"Noninvasive brain delivery and efficacy of BDNF to stimulate neuroregeneration and suppression of disease relapse in EAE mice","volume":"17","author":"Kopec","year":"2020","journal-title":"Mol Pharm"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404887101","article-title":"Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications","author":"Arnon","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.03.010","article-title":"Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy","volume":"233","author":"Ziemssen","year":"2005","journal-title":"J Neurological Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-510X(03)00177-1","article-title":"Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor","volume":"215","author":"Chen","year":"2003","journal-title":"J Neurol Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.07.043","article-title":"Effect of glatiramer acetate (Copaxone\u00ae) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study","volume":"406","author":"Blanco","year":"2006","journal-title":"Neurosci Letters"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2009.04.004","article-title":"Interferon-\u03b2 therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism","volume":"211","author":"Azoulay","year":"2009","journal-title":"J Neuroimmunology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.02.016","article-title":"Fingolimod inhibits brain atrophy and promotes brain-derived neurotrophic factor in an animal model of multiple sclerosis","volume":"318","author":"Smith","year":"2018","journal-title":"J Neuroimmunology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00675-7","article-title":"Fingolimod increases brain-derived neurotrophic factor level secretion from circulating T cells of patients with multiple sclerosis","volume":"33","author":"Golan","year":"2019","journal-title":"CNS Drugs"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/jez.1401160206","article-title":"Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo","volume":"116","author":"Levi-Montalcini","year":"1951","journal-title":"J Exp Zool"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S247472","article-title":"Nerve growth factor signaling and its contribution to pain","volume":"13","author":"Barker","year":"2020","journal-title":"J Pain Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/1570159X13666150403231920","article-title":"Nerve growth factor: A focus on neuroscience and therapy","volume":"13","author":"Aloe","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2014.04.010","article-title":"Nerve growth factor metabolic dysfunction in Alzheimer\u2019s disease and Down syndrome","volume":"35","author":"Iulita","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45100489","article-title":"Therapeutic plasma exchange and multiple sclerosis dysregulations: focus on the removal of pathogenic circulatory factors and altering nerve growth factor and sphingosine-1-phosphate plasma levels","volume":"45","author":"Tonev","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10245","article-title":"Oligodendrocytes as providers of growth factors","volume":"68","author":"Du","year":"2002","journal-title":"J Neurosci Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111835","article-title":"A microglial function for the nerve growth factor: predictions of the unpredictable","volume":"11","author":"Tiberi","year":"2022","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18051028","article-title":"NGF and its receptors in the regulation of inflammatory response","volume":"18","author":"Minnone","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-020-1708-9","article-title":"Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis","volume":"17","author":"Delivanoglou","year":"2020","journal-title":"J Neuroinflammation"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23170","article-title":"The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone-induced death, through the NGF receptor TrkA","volume":"65","author":"Bonetto","year":"2017","journal-title":"Glia"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1111170","article-title":"Nerve growth factor promotes differentiation and protects the oligodendrocyte precursor cells from in vitro hypoxia\/ischemia","volume":"17","author":"Baldassarro","year":"2023","journal-title":"Front Neurosci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.3390\/ijms21165911","article-title":"R-ras GTPases signaling role in myelin neurodegenerative diseases","volume":"21","author":"Alcover-Sanchez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3360-14.2014","article-title":"Role of ERK1\/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS","volume":"34","author":"Ishii","year":"2014","journal-title":"J Neurosci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23312","article-title":"NGF steers microglia toward a neuroprotective phenotype","volume":"66","author":"Rizzi","year":"2018","journal-title":"Glia"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1165125","article-title":"Reduced levels of NGF shift astrocytes toward a neurotoxic phenotype","volume":"11","author":"Tiberi","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.3390\/ijms24098332","article-title":"Genetically engineered artificial microvesicles carrying nerve growth factor restrains the progression of autoimmune encephalomyelitis in an experimental mouse model","volume":"24","author":"Alatrash","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/2277-9175.151570","article-title":"Neurotrophic factors and their effects in the treatment of multiple sclerosis","volume":"4","author":"Razavi","year":"2015","journal-title":"Adv BioMed Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.01.022","article-title":"Lipopolysaccharide-induced nigral inflammation leads to increased IL-1\u03b2 tissue content and expression of astrocytic glial cell line-derived neurotrophic factor","volume":"510","author":"Iravani","year":"2012","journal-title":"Neurosci Lett"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2010.00258.x","article-title":"Glial cell line-derived neurotrophic factor is expressed by inflammatory cells in the sciatic nerves of Lewis rats with experimental autoimmune neuritis","volume":"15","author":"Ahn","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020456","article-title":"GDNF, A neuron-derived factor upregulated in glial cells during disease","volume":"9","author":"Duarte Azevedo","year":"2020","journal-title":"J Clin Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson\u2019s disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington\u2019s disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","article-title":"Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis","volume":"22","author":"Wang","year":"2002","journal-title":"J Neurosci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2008.11.016","article-title":"Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity","volume":"33","author":"Sandhu","year":"2009","journal-title":"Neurobiol Disease"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46100693","article-title":"Exploring the gene expression and plasma protein levels of HSP90, HSP60, and GDNF in multiple sclerosis patients and healthy controls","volume":"46","author":"Sokolowski","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300203","article-title":"The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model","volume":"19","author":"Imraish","year":"2024","journal-title":"PLoS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41419-022-05202-z","article-title":"Astrocytic SARM1 promotes neuroinflammation and axonal demyelination in experimental autoimmune encephalomyelitis through inhibiting GDNF signaling","volume":"13","author":"Jin","year":"2022","journal-title":"Cell Death Disease"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190347","article-title":"Historical overview of the interleukin-6 family cytokine","volume":"217","author":"Kang","year":"2020","journal-title":"J Exp Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3892\/mmr.2024.13396","article-title":"Ciliary neurotrophic factor activation of astrocytes mediates neuronal damage via the IL\u22126\/IL\u22126R pathway","volume":"31","author":"Wang","year":"2025","journal-title":"Mol Med Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10048","article-title":"CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain","volume":"37","author":"Dallner","year":"2002","journal-title":"Glia"},{"key":"B107","article-title":"Expression of ciliary neurotrophic factor (CNTF) and its tripartite receptor complex by cells of the human optic nerve head","volume":"13","author":"Liu","year":"2007","journal-title":"Mol Vis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm206","article-title":"Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients","volume":"130","author":"Dutta","year":"2007","journal-title":"Brain"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1126\/science.2011743","article-title":"Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor","volume":"251","author":"Oppenheim","year":"1991","journal-title":"Science"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/335070a0","article-title":"Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture","volume":"335","author":"Hughes","year":"1988","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-21-09221.2002","article-title":"Ciliary neurotrophic factor (CNTF) enhances myelin formation: A novel role for CNTF and CNTF-related molecules","volume":"22","author":"Stankoff","year":"2002","journal-title":"J Neurosci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/neu.480251111","article-title":"The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines","volume":"25","author":"Stahl","year":"1994","journal-title":"J Neurobiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210044200","article-title":"Signaling of human ciliary neurotrophic factor (CNTF) revisited: THE INTERLEUKIN-6 RECEPTOR CAN SERVE AS AN &x3b1;-RECEPTOR FOR CNTF *","volume":"278","author":"Schuster","year":"2003","journal-title":"J Biol Chem"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1238453","article-title":"Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis","volume":"16","author":"Stansberry","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022623","article-title":"Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming","volume":"6","author":"Gudi","year":"2011","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/nm0602-620","article-title":"CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation","volume":"8","author":"Linker","year":"2002","journal-title":"Nat Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2013.00044","article-title":"Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model","volume":"7","author":"Fang","year":"2013","journal-title":"Front Neuroanat"},{"key":"B118","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2008.10.014","article-title":"Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice","volume":"206","author":"Lu","year":"2009","journal-title":"J Neuroimmunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1126\/science.1840698","article-title":"A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF","volume":"251","author":"Higashiyama","year":"1991","journal-title":"Science"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1080\/08977190400008448","article-title":"Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways","volume":"22","author":"Nishi","year":"2004","journal-title":"Growth Factors"},{"key":"B121","article-title":"Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer","volume":"32","author":"Miyata","year":"2012","journal-title":"Anticancer Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22565","article-title":"Roles for HB-EGF and CD9 in multiple sclerosis","volume":"61","author":"Schenk","year":"2013","journal-title":"Glia"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-13-05365.2002","article-title":"Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo","volume":"22","author":"Jin","year":"2002","journal-title":"J Neurosci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12974-015-0393-6","article-title":"Fingolimod induces neuroprotective factors in human astrocytes","volume":"12","author":"Hoffmann","year":"2015","journal-title":"J Neuroinflammation"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14917","article-title":"Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes","volume":"153","author":"Tran","year":"2020","journal-title":"J Neurochemistry"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.26.582092","article-title":"HB-EGF and EGF infusion following CNS demyelination mitigates age-related decline in regeneration of oligodendrocytes from neural precursor cells originating in the ventricular-subventricular zone","author":"Moradi","year":"2024","journal-title":"bioRxiv"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01799-07","article-title":"DNA methylation inhibitor 5-Aza-2\u2019-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B","volume":"28","author":"Palii","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2013.00159","article-title":"Low-dose 5-aza-2\u2019-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells","volume":"20","author":"Chan","year":"2014","journal-title":"Mol Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3681","article-title":"Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation","volume":"20","author":"Mayo","year":"2014","journal-title":"Nat Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21088","article-title":"Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease","volume":"59","author":"Toft-Hansen","year":"2011","journal-title":"Glia"},{"key":"B131","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-neuro-070918-050443","article-title":"The emerging nature of astrocyte diversity","volume":"42","author":"Khakh","year":"2019","journal-title":"Annu Rev Neurosci"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05534-y","article-title":"Microglia regulate central nervous system myelin growth and integrity","volume":"613","author":"McNamara","year":"2023","journal-title":"Nature"},{"key":"B133","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","article-title":"Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia","volume":"24","author":"Dong","year":"2021","journal-title":"Nat Neurosci"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190812","article-title":"CNS-localized myeloid cells capture living invading T cells during neuroinflammation","volume":"217","author":"Wasser","year":"2020","journal-title":"J Exp Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/BF02340121","article-title":"Nerve growth factor (NGF) in cerebrospinal fluid (CSF) from patients with various neurological disorders","volume":"15","author":"Massaro","year":"1994","journal-title":"Ital J Neurological Sci"},{"key":"B136","article-title":"Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie. Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg), Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"Hemmer","year":"2024"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15091178","article-title":"Neurodegenerative biomarkers in multiple sclerosis: at the interface between research and clinical practice","volume":"15","author":"Ciubotaru","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neubiorev.2019.04.015","article-title":"Postmortem brain tissue as an underutilized resource to study the molecular pathology of neuropsychiatric disorders across different ethnic populations","volume":"102","author":"Vornholt","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"B139","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-015-0126-1","article-title":"Post-mortem analysis of neuroinflammatory changes in human Alzheimer\u2019s disease","volume":"7","author":"Gomez-Nicola","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3109\/10611860903318134","article-title":"Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS","volume":"18","author":"Alcal\u00e1-Barraza","year":"2010","journal-title":"J Drug Targeting"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13804","article-title":"The application of polymeric nanoparticles as drug delivery carriers to cells in neurodegenerative diseases","volume":"58","author":"Jin","year":"2025","journal-title":"Cell Proliferation"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2308677","DOI":"10.1002\/advs.202308677","article-title":"Progress in the treatment of central nervous system diseases based on nanosized traditional chinese medicine","volume":"11","author":"Li","year":"2024","journal-title":"Advanced Science"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj5958","article-title":"Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice","volume":"16","author":"Gaikwad","year":"2024","journal-title":"Sci Trans Med"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084153","article-title":"Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","article-title":"Intranasal administration of interferon beta bypasses the blood\u2013brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis","volume":"151","author":"Ross","year":"2004","journal-title":"J Neuroimmunology"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800128","article-title":"Astrocyte-derived pleiotrophin mitigates late-stage autoimmune CNS inflammation","volume":"12","author":"Linnerbauer","year":"2022","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00456-3","article-title":"Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a\/2b superiority trial","volume":"24","author":"Coleman","year":"2025","journal-title":"Lancet Neurology"},{"key":"B150","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose-to-brain delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.12.013","article-title":"Targeting specific cells in the brain with nanomedicines for CNS therapies","volume":"240","author":"Zhang","year":"2016","journal-title":"J Controlled Release"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: What do we know","volume":"71","author":"Kreuter","year":"2014","journal-title":"Advanced Drug Delivery Rev"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043866","article-title":"Neurotrophic factors as regenerative therapy for neurodegenerative diseases: current status, challenges and future perspectives","volume":"24","author":"El Ouaamari","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011187","article-title":"Application of mesenchymal stem cells in targeted delivery to the brain: potential and challenges of the extracellular vesicle-based approach for brain tumor treatment","volume":"22","author":"Do","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B155","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/pharmaceutics16020289","article-title":"Mesenchymal Stem Cell (MSC)-Based Drug Delivery into the Brain across the Blood\u2013Brain Barrier","volume":"16","author":"Tashima","year":"2024","journal-title":"Pharmaceutics"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319130015","article-title":"Mesenchymal stem\/stromal cells: a new \u2018\u2018cells as drugs\u2019\u2019 paradigm. Efficacy and critical aspects in cell therapy","volume":"19","author":"de Girolamo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.01.057","article-title":"A small-molecule screen for enhanced homing of systemically infused cells","volume":"10","author":"Levy","year":"2015","journal-title":"Cell Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/nm1703","article-title":"Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone","volume":"14","author":"Sackstein","year":"2008","journal-title":"Nat Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-02003-9","article-title":"A cell-based drug delivery platform for treating central nervous system inflammation","volume":"99","author":"Levy","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"B160","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jneuroim.2009.02.017","article-title":"Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle","volume":"210","author":"Makar","year":"2009","journal-title":"J Neuroimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1654603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T04:13:51Z","timestamp":1756268031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1654603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2025.1654603"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1654603","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"article-number":"1654603"}}